Advanced Coats' disease: Management with repetitive aggressive laser ablation therapy

Amy C. Schefler, Audina Berrocal, Timothy G. Murray

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

PURPOSE: To review the rates of globe salvage and final visual acuity outcomes for patients undergoing repetitive laser ablation therapy for advanced Coats' disease. METHODS: This study was a retrospective chart review of all patients diagnosed with primary Coats' disease treated on the Ocular Oncology Service of the Bascom Palmer Eye Institute from 1991-2006. Patients underwent repetitive diode laser ablation (two to nine sessions) to telangiectatic vessels and areas of exudative retinal detachment. Main outcome measures included ability to achieve globe salvage, final visual acuity, and anatomic success. RESULTS: Seventeen patients were identified who met all of the inclusion criteria for the study. All of the eyes in this study had advanced disease with some degree of exudation with or without a retinal detachment. The median length of follow-up was 10 months (mean, 21 months). The median number of laser applications required was 4.8 (mean, 5). Fourteen patients (82%) achieved anatomic success with complete resolution of the telangiectasis and exudative retinal detachments. Sixteen patients (94%) achieved globe salvage. The final visual acuity was excellent (20/20-20/50) in 7 patients (47%), moderate (20/60-20/100) in 1 patient (7%), and poor (worse than 20/200) in 7 patients (47%). CONCLUSION: A majority of patients with Coats' disease can achieve globe salvage and about half of patients can retain useful vision with aggressive repetitive diode laser therapy even if the disease is very advanced at presentation.

Original languageEnglish
JournalRetina
Volume28
Issue number3 SUPPL.
DOIs
StatePublished - Mar 1 2008

Fingerprint

Retinal Telangiectasis
Laser Therapy
Disease Management
Retinal Detachment
Visual Acuity
Semiconductor Lasers
Telangiectasis
Aptitude

Keywords

  • Coats' disease
  • Enucleation
  • Exudative retinal detachment
  • Globe salvage
  • Laser therapy

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Advanced Coats' disease : Management with repetitive aggressive laser ablation therapy. / Schefler, Amy C.; Berrocal, Audina; Murray, Timothy G.

In: Retina, Vol. 28, No. 3 SUPPL., 01.03.2008.

Research output: Contribution to journalArticle

Schefler, Amy C. ; Berrocal, Audina ; Murray, Timothy G. / Advanced Coats' disease : Management with repetitive aggressive laser ablation therapy. In: Retina. 2008 ; Vol. 28, No. 3 SUPPL.
@article{e56f07633a394d51bade8be87dc80b0d,
title = "Advanced Coats' disease: Management with repetitive aggressive laser ablation therapy",
abstract = "PURPOSE: To review the rates of globe salvage and final visual acuity outcomes for patients undergoing repetitive laser ablation therapy for advanced Coats' disease. METHODS: This study was a retrospective chart review of all patients diagnosed with primary Coats' disease treated on the Ocular Oncology Service of the Bascom Palmer Eye Institute from 1991-2006. Patients underwent repetitive diode laser ablation (two to nine sessions) to telangiectatic vessels and areas of exudative retinal detachment. Main outcome measures included ability to achieve globe salvage, final visual acuity, and anatomic success. RESULTS: Seventeen patients were identified who met all of the inclusion criteria for the study. All of the eyes in this study had advanced disease with some degree of exudation with or without a retinal detachment. The median length of follow-up was 10 months (mean, 21 months). The median number of laser applications required was 4.8 (mean, 5). Fourteen patients (82{\%}) achieved anatomic success with complete resolution of the telangiectasis and exudative retinal detachments. Sixteen patients (94{\%}) achieved globe salvage. The final visual acuity was excellent (20/20-20/50) in 7 patients (47{\%}), moderate (20/60-20/100) in 1 patient (7{\%}), and poor (worse than 20/200) in 7 patients (47{\%}). CONCLUSION: A majority of patients with Coats' disease can achieve globe salvage and about half of patients can retain useful vision with aggressive repetitive diode laser therapy even if the disease is very advanced at presentation.",
keywords = "Coats' disease, Enucleation, Exudative retinal detachment, Globe salvage, Laser therapy",
author = "Schefler, {Amy C.} and Audina Berrocal and Murray, {Timothy G.}",
year = "2008",
month = "3",
day = "1",
doi = "10.1097/IAE.0b013e318163cd7c",
language = "English",
volume = "28",
journal = "Retina",
issn = "0275-004X",
publisher = "Lippincott Williams and Wilkins",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Advanced Coats' disease

T2 - Management with repetitive aggressive laser ablation therapy

AU - Schefler, Amy C.

AU - Berrocal, Audina

AU - Murray, Timothy G.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - PURPOSE: To review the rates of globe salvage and final visual acuity outcomes for patients undergoing repetitive laser ablation therapy for advanced Coats' disease. METHODS: This study was a retrospective chart review of all patients diagnosed with primary Coats' disease treated on the Ocular Oncology Service of the Bascom Palmer Eye Institute from 1991-2006. Patients underwent repetitive diode laser ablation (two to nine sessions) to telangiectatic vessels and areas of exudative retinal detachment. Main outcome measures included ability to achieve globe salvage, final visual acuity, and anatomic success. RESULTS: Seventeen patients were identified who met all of the inclusion criteria for the study. All of the eyes in this study had advanced disease with some degree of exudation with or without a retinal detachment. The median length of follow-up was 10 months (mean, 21 months). The median number of laser applications required was 4.8 (mean, 5). Fourteen patients (82%) achieved anatomic success with complete resolution of the telangiectasis and exudative retinal detachments. Sixteen patients (94%) achieved globe salvage. The final visual acuity was excellent (20/20-20/50) in 7 patients (47%), moderate (20/60-20/100) in 1 patient (7%), and poor (worse than 20/200) in 7 patients (47%). CONCLUSION: A majority of patients with Coats' disease can achieve globe salvage and about half of patients can retain useful vision with aggressive repetitive diode laser therapy even if the disease is very advanced at presentation.

AB - PURPOSE: To review the rates of globe salvage and final visual acuity outcomes for patients undergoing repetitive laser ablation therapy for advanced Coats' disease. METHODS: This study was a retrospective chart review of all patients diagnosed with primary Coats' disease treated on the Ocular Oncology Service of the Bascom Palmer Eye Institute from 1991-2006. Patients underwent repetitive diode laser ablation (two to nine sessions) to telangiectatic vessels and areas of exudative retinal detachment. Main outcome measures included ability to achieve globe salvage, final visual acuity, and anatomic success. RESULTS: Seventeen patients were identified who met all of the inclusion criteria for the study. All of the eyes in this study had advanced disease with some degree of exudation with or without a retinal detachment. The median length of follow-up was 10 months (mean, 21 months). The median number of laser applications required was 4.8 (mean, 5). Fourteen patients (82%) achieved anatomic success with complete resolution of the telangiectasis and exudative retinal detachments. Sixteen patients (94%) achieved globe salvage. The final visual acuity was excellent (20/20-20/50) in 7 patients (47%), moderate (20/60-20/100) in 1 patient (7%), and poor (worse than 20/200) in 7 patients (47%). CONCLUSION: A majority of patients with Coats' disease can achieve globe salvage and about half of patients can retain useful vision with aggressive repetitive diode laser therapy even if the disease is very advanced at presentation.

KW - Coats' disease

KW - Enucleation

KW - Exudative retinal detachment

KW - Globe salvage

KW - Laser therapy

UR - http://www.scopus.com/inward/record.url?scp=43149101857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43149101857&partnerID=8YFLogxK

U2 - 10.1097/IAE.0b013e318163cd7c

DO - 10.1097/IAE.0b013e318163cd7c

M3 - Article

C2 - 18317343

AN - SCOPUS:43149101857

VL - 28

JO - Retina

JF - Retina

SN - 0275-004X

IS - 3 SUPPL.

ER -